Qingdao Baheal Financials
| 301015 Stock | 27.53 0.20 0.73% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 676.5 M | 938.2 M |
|
|
Qingdao | Select Account or Indicator |
Understanding current and past Qingdao Baheal Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Qingdao Baheal's financial statements are interrelated, with each one affecting the others. For example, an increase in Qingdao Baheal's assets may result in an increase in income on the income statement.
Please note, the presentation of Qingdao Baheal's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Qingdao Baheal's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Qingdao Baheal's management manipulating its earnings.
Qingdao Baheal Stock Summary
Qingdao Baheal competes with Cultural Investment, Gome Telecom, Holitech Technology, and Zotye Automobile. Qingdao Baheal is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE100004LR8 |
| Business Address | No 88 Kaifeng |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.bahealpharma.com |
| Phone | 86 53 26675 6688 |
You should never invest in Qingdao Baheal without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Qingdao Stock, because this is throwing your money away. Analyzing the key information contained in Qingdao Baheal's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Qingdao Baheal Key Financial Ratios
Qingdao Baheal's financial ratios allow both analysts and investors to convert raw data from Qingdao Baheal's financial statements into concise, actionable information that can be used to evaluate the performance of Qingdao Baheal over time and compare it to other companies across industries.| Revenue | 7.56 B | ||||
| Gross Profit | 2.08 B | ||||
| EBITDA | 999.94 M | ||||
| Net Income | 656.31 M | ||||
| Total Asset | 5.3 B |
Qingdao Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Qingdao Baheal's current stock value. Our valuation model uses many indicators to compare Qingdao Baheal value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Qingdao Baheal competition to find correlations between indicators driving Qingdao Baheal's intrinsic value. More Info.Qingdao Baheal Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Qingdao Baheal Medical is roughly 2.61 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Qingdao Baheal by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Qingdao Baheal's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Qingdao Baheal Medical Systematic Risk
Qingdao Baheal's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Qingdao Baheal volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Qingdao Baheal Medical correlated with the market. If Beta is less than 0 Qingdao Baheal generally moves in the opposite direction as compared to the market. If Qingdao Baheal Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Qingdao Baheal Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Qingdao Baheal is generally in the same direction as the market. If Beta > 1 Qingdao Baheal moves generally in the same direction as, but more than the movement of the benchmark.
Qingdao Baheal Medical Total Assets Over Time
Qingdao Baheal Thematic Clasifications
Qingdao Baheal Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Qingdao Baheal December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Qingdao Baheal help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Qingdao Baheal Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Qingdao Baheal Medical based on widely used predictive technical indicators. In general, we focus on analyzing Qingdao Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Qingdao Baheal's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.95 | |||
| Information Ratio | 0.0536 | |||
| Maximum Drawdown | 30.29 | |||
| Value At Risk | (5.34) | |||
| Potential Upside | 8.4 |
Complementary Tools for Qingdao Stock analysis
When running Qingdao Baheal's price analysis, check to measure Qingdao Baheal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Qingdao Baheal is operating at the current time. Most of Qingdao Baheal's value examination focuses on studying past and present price action to predict the probability of Qingdao Baheal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Qingdao Baheal's price. Additionally, you may evaluate how the addition of Qingdao Baheal to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |